NUGX Share Price Performance
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
NuGenerex Immuno-Oncology, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
NUGX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
NuGenerex Immuno-Oncology, Inc. Key Details
About NUGX
- Founded
- 1993
- Employees
- n/a
- CEO
- WebsiteView website
NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.
Recent NUGX News & Updates
No updates
